Description
A fixed-ratio blend of ipamorelin, a selective ghrelin-receptor agonist, and tesamorelin, a full-length GHRH (1-44) analogue stabilized with a trans-3-hexenoyl group.
Research context
The pairing lets researchers look at GHRH-receptor and ghrelin-receptor stimulation together in one preparation.
Specifications
| Amount per vial | 10 mg total (5 mg + 5 mg) |
|---|---|
| Form | Lyophilized (freeze-dried) powder in a sealed glass vial |
| Storage | Store sealed vials at −20 °C, away from light. Once reconstituted, keep at 2–8 °C. |
| Intended use | In-vitro and laboratory research only |
For laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or supplement. Sold only to qualified researchers who accept our Research Use Policy.
Reviews
There are no reviews yet.